English
Les études
cliniques
HomeSTUDY RETRO
A retrospective study demonstratingthe clinical efficacy and safety of S³ Monitor
L’étude RETRO est une étude multicentrique française mettant l’accent sur la quantification des performances d’épuration lors du traitement par hémodialyse fréquente et courte à domicile effectué pendant la période de formation des patients, en milieu hospitalier1.Study Description
RETROSPECTIVE DATA
13 centers
80 patients in training on S³
249 sessions analyzed
Study period: 2013-2017
Hemodialysis with S³ offers
EFFICACY IN COMPLIANCE WITH RECOMMENDATIONS KDOQI
Particularly regarding the Kt/V of urea
THE PATIENT'S METABOLIC NEEDS ARE LARGELY MET
Specifically in terms of the clearance of creatinine, potassium, and phosphate.
PROVEN SAFETY AND EFFICACY
The trained patients were successfully set up at home without medical issues.
RECAPSTUDY
A retrospective study demonstratingthe clinical efficacy and safety of S³ Monitor
The RECAP study is a French multicenter study with a two-year follow-up, aimed at quantifying the efficacy achieved with the S³ system, used for frequent home hemodialysis treatments. It provides a detailed analysis of the patient profile treated with this therapy in terms of age, body mass index, and residual kidney function, and confirms the clinical efficacy of Frequent HHD³.
Study Description
RETROSPECTIVE DATA
10 centers
92 Patients
2 years of follow-up
Study period: 2016-2018
Hemodialysis with S³ offers
SUITABLE FOR A WIDE RANGE OF PATIENTS
Regardless of age, BMI, or comorbidities.
CONFIRMED EFFICACY (UREA)
In terms of clearance.
PROVEN SAFETY
With stable biological markers such as phosphate and a favorable evolution of albuminemia.
IMC=indice de masse corporelle
IMPROVEMENT IN CLINICAL STATUS
With an improvement in hemodynamic stability and a reduction in left ventricular hypertrophy.
EVOLUTION IN PROFESSIONAL SITUATION
25% of patients resumed work during the period.
